KAI Pharmaceuticals Announces Initiation of Phase 1b Study of KAI-4169 for the ... - Business Wire (press release) PDF Print
Business Wire (press release)Secondary hyperparathyroidism develops early in chronic kidney disease (CKD) and worsens as renal function declines and progresses to end-stage renal

... read more

 
Share |
Copyright © 2025 Global Dialysis. All Rights Reserved.